Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nanalysis Scientific Corp.
V.NSCI
Alternate Symbol(s):
NSCIF
Healthcare
Medical Devices
Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research...
labs around the world.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:NSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(1541)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Apr 12, 2023 9:27am
RE:Where is Q4? And no announcements
Just announced. April 27 after market
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 12, 2023 8:31am
New Press Release - Nanalysis Announces Fourth Quarter and Full Year 2022 Conference Call
Hosting Call at 5:00 pm ET on Thursday, April 27thEuropean Q&A Session on April 28th at 8:30am ETCALGARY, AB, April 12, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and...
read article.
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Apr 10, 2023 2:42pm
I'm out
This company is deadsville. no news, no earnings, no anything. Not sure what happened here but the stroy seemed real good.
(20)
•••
Baconator
X
View Profile
View Bullboard History
Comment by
Baconator
on Apr 10, 2023 10:51am
RE:Where is Q4? And no announcements
Due by the end of the month. They have an extra month on this exchange. Hardly horrible management, easily found by looking back at last year.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Apr 06, 2023 1:23pm
Where is Q4? And no announcements
Horrible management. Where is Q4? Anyone know when Q4 year end is coming? Anyone still on this board other than me?
(1)
•••
JayBe
X
View Profile
View Bullboard History
Comment by
JayBe
on Mar 14, 2023 3:52pm
RE:Management are Ghost
Hey I like the options...they are so far out of the money a....looks good for shareholders....financials likley delayed due to approval of stock option plan...they represent only 1/3 of 1% or so of
...more
(20)
•••
Baconator
X
View Profile
View Bullboard History
Comment by
Baconator
on Mar 14, 2023 1:57pm
RE:Management are Ghost
Hard at work. Lots of irons in the fire. Looking forward to the quarterly
(9)
•••
GoldenArm1
X
View Profile
View Bullboard History
Post by
GoldenArm1
on Mar 14, 2023 12:18pm
Management are Ghost
Nothing from the company in so long. Only how they have given themselves more shares. What happened here? 1 year later and we are below 0.70/shr. I guess nothing has changed and the company has no
...more
(20)
•••
Baconator
X
View Profile
View Bullboard History
Comment by
Baconator
on Feb 14, 2023 5:54pm
RE:Financial and Corporate Update Coming soon
What makes you say that?
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Feb 09, 2023 11:56am
Financial and Corporate Update Coming soon
They should announce today or tomorrow when they intend to update. I'm hoping it will be Wednesday or Thursday next week for numbers. Personally I hate Friday announcements.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Feb 09, 2023 8:49am
RE:reduced use of helium by a large competitor
These are big machines that require a room to contain them. 1GHz is cool but 4°K is still cold and NSCI is benchtop, no Cryo, used for identification and not resonance studies at a sub atomic
...more
(1541)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Feb 03, 2023 9:01am
reduced use of helium by a large competitor
Hurts the economics of purchase potentially? Keep in mind NCSI's portable devices require no liquid helium or any other cryogens Bruker Announces Successful Customer Installations of
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 30, 2022 1:00pm
Echelon maintains $2.75 target price.
Nanalysis Scientific has a huge upside, says Echelon - Cantech Letter
(5)
•••
rowdyrhino
X
View Profile
View Bullboard History
Post by
rowdyrhino
on Oct 30, 2022 9:47am
3X Your Money in 2023 with Nanalysis
3X Your Money in 2023 with Nanalysis https://medium.com/right-way-investing/3x-your-money-in-2023-with-nanalysis-b73afaf92fb8
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Oct 27, 2022 1:53pm
Strong growth 100%
Looks like the market for them is coming back strongly. Get in now IMHO Preliminary Q3 Revenue Expected to be at least $6.8 million The Company looks to report gross
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims